Reply to: Non-invasive tests and advanced chronic liver disease in NAFLD: two steps forward and one step back?
暂无分享,去创建一个
[1] M. Ronot,et al. Liver surface nodularity on non-contrast MRI identifies advanced fibrosis in patients with NAFLD , 2021, European Radiology.
[2] E. Tsochatzis,et al. Non-invasive tests and advanced chronic liver disease in NAFLD: two steps forward and one step back? , 2021, Gut.
[3] V. Wong,et al. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis , 2021, Gut.
[4] V. Wong,et al. Liver stiffness measurement predicts long‐term survival and complications in non‐alcoholic fatty liver disease , 2019, Liver international : official journal of the International Association for the Study of the Liver.
[5] S. Asch,et al. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease. , 2018, Gastroenterology.
[6] V. Wong,et al. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis. , 2018, Journal of hepatology.
[7] P. Schirmacher,et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.
[8] R. Franchis. Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension , 2015 .
[9] G. Práctica,et al. European Association for the Study of the Liver , 1971 .
[10] R. de Franchis. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. , 2015, Journal of hepatology.